SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · United Therapeutics CEO Martine Rothblatt conducted a series of…

UNITED THERAPEUTICS Corp · CLUSTER filed Mar 16, 2026 at 16:31 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Mar 16, 2026 at 16:31 ET

United Therapeutics CEO Martine Rothblatt conducted a series of derivative exercises and open-market sales over the past week, including over $2.2 million in share sales. Director Malcolm Jan and Director Judy Olian also sold smaller amounts. The majority of the economic activity stems from Rothblatt monetizing previously held options.

  • CEO Martine Rothblatt sold 2,100 shares in open-market transactions totaling ~$1.13 million over three days (March 12–16).
  • Rothblatt exercised 38,000 derivative securities across four transactions, with 19,000 at $0 cost and 19,000 at $146.03 strike price, unlocking ~$2.77 million in value.
  • Total open-market sales by insiders in the cluster: 2,795 shares, ~$1.43 million.
  • Directors Malcolm Jan and Judy Olian sold 45 and 200 shares respectively for $24K and $107K, small relative to CEO activity.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access